News ArchivesRead News
23andMe Helps Make New Parkinson's Disease Discovery
Monday July 28, 2014
Stephanie M. Lee
SFGate.com - 23andMe, the Google-backed genetic testing startup in Mountain View, has once again helped make a discovery about Parkinson's disease.
In a paper published this week in the scientific journal Nature Genetics, the company was one of more than 50 institutions worldwide that described new genetic risks for Parkinson's disease. In particular, they determined for the first time six loci, or locations of specific genes on chromosomes, to be associated with Parkinson's. The researchers also confirmed two dozen known genetic associations with Parkinson's.
The study was enormous. It looked at 7 million variants in about 13,000 patients with Parkinson's and, for a control group, more than 100,000 people who did not have the disease. 23andMe contributed data from more than 4,000 customers with Parkinson's and about 62,000 without it, all of whom consented to participate in the research.
23andMe runs a community that specifically aims to crowdsource genetic information about Parkinson's. More than 10,000 diagnosed patients, it says, have mailed in DNA samples and answered online questions about their illness in the name of advancing scientific research. In return, the participants can also obtain information about their ancestry and gain access to their raw genetic data. (As of November, 23andMe can no longer sell saliva kits that tell people about their personal health risks, but it is taking steps to win the U.S. Food and Drug Administration's approval.)
This isn't the first time 23andMe has made a Parkinson's discovery. In a 2011 paper, the company reported that it had found two new genetic associations with the disease, including one near a gene involved with pathways known to be associated with Parkinson's.
Why is 23andMe so interested in Parkinson's? It may be because co-founder and CEO Anne Wojcicki's husband, Google executive Sergey Brin, has a genetic variation that puts him at risk of developing the disease. (The two are separated.) In 2013, the couple gave $32 million to the Michael J. Fox Foundation for Parkinson's Research.
Recent NewsSep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement